• Profile
Close

Global TB death rate in under-fives reported for first time

The University of Sheffield News Aug 24, 2017

Tuberculosis (TB) is thought to have affected more than one million children under 15 worldwide in 2015. Diagnosis of TB in children can be challenging, partly due to insensitive tests and non–specific symptoms. Although younger children are vulnerable to severer forms of the disease, there are currently no estimates of the mortality rate for under–fives.

New modelling by researchers from a team including University of Sheffield’s world–leading School of Health and Related Research (ScHARR) estimates 239,000 children aged 14 years and under died from TB worldwide in 2015. Researchers from Boston University (USA), Brigham and Women’s Hospital and Harvard Medical School (USA), Imperial College (UK) and the World Health Organization also contributed.

Lead author, Pete Dodd from the University of Sheffield, said: “We estimate 239,000 children died from TB in 217 countries in 2015 – 80 per cent of these were children under five years of age. This makes TB a top 10 cause of death in the age group.

“The vast majority of deaths – over 96 per cent – were in children not receiving treatment for the disease. Given excellent treatment outcomes, this highlights the scope to reduce this toll by improving treatment coverage.”

He added: “Historically, TB in children has not received the attention that it might have done. The World Health Organization has been encouraging countries to report the number of TB cases they find in children by age group.”

Co–author, Helen Jenkins, Assistant Professor at Boston University School of Public Health, said: “This should be a call to action: TB is preventable and treatable and we must do more to stop these unnecessary deaths in children”.

Under–five mortality was a key indicator in the Millennium Development Goals and the subsequent Sustainable Development Goals, and is tracked by the UN Inter–agency Group on Child Mortality Estimation (IGME). These estimates have been important in assessing progress towards targets, directing public health funding and spending, and for advocacy.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay